Phase III study of efficacy of fondaparinux on the prevention of post-operative venous thromboembolism in patients undergoing with laparoscopic colorectal cancer surgery.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2623843
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Once daily fondaparinux (2.5mg or 1.5mg) for 4 to 8 days after 24 hours of surgery
Intermittent pneumatic compression according to the institutional guidelines
Primary outcome(s): Incidence of venous thromboembolism (VTE)
Study Design: Parallel Randomized
创建时间：
2012-09-15
